Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
$ 18.50 · 5 (159) · In stock
Frontiers Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows – Washington University School of Medicine in St. Louis
Cancers, Free Full-Text
Hutch News Fred Hutchinson Cancer Center
Immunotherapy for pancreatic cancer boosts survival by more than 75% in mice
The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression
A new model for pancreatic cancer research: Flexible, precision-medicine trial 'driven by doing what is best for the individual patient
Hutch News Fred Hutchinson Cancer Center